Pharmaceuticals
10 DEA controlled substances compliance experts
These ten professionals have run DEA controlled substances compliance at drug manufacturers and distributors, and some held diversion, enforcement and policy roles at the Drug Enforcement Administration or advise registrants as counsel. A reader can learn how practitioners approach DEA compliance from people who have done the work.
Professionals to explore
01—10Brianne Clarke-White
LinkedInExperience: Manager, DEA Compliance · Amneal Pharmaceuticals
Former Manager, DEA Compliance at Amneal Pharmaceuticals (2021–2026), after serving there as Senior DEA Compliance Auditor (2020–2021), and Manager, Controlled Substance at Regeneron since 2026. Earlier she was a Compliance Analyst at Rochester Drug Cooperative (2018–2020). The profile describes 11+ years in DEA and controlled substance compliance, covering ARCOS, suspicious order monitoring, security, licensing and audits.
David Gourley
LinkedInExperience: Associate Director for DEA Compliance and Security · Amneal Pharmaceuticals
Former Associate Director for DEA Compliance and Security at Amneal Pharmaceuticals (2019–2024), and Director of Compliance at Quest Pharmaceuticals since 2024, where the profile says he manages the suspicious order monitoring system and DEA and state reporting and reviews customer onboarding. Earlier he was an Assistant Special Agent in Charge at the Drug Enforcement Administration (2016–2018).
Eric Owen
LinkedInExperience: Associate Director Regulatory Affairs, DEA · Perrigo Company plc
Associate Director Regulatory Affairs, DEA at Perrigo Company plc since 2018, after serving as DEA Compliance Manager at Beach Products/Pharmaceutical Associates (2013–2018) and in DEA compliance at Southern Anesthesia & Surgical (2009–2013). The profile says he is responsible for the DEA corporate compliance program and state licensing, and leads the DEA inspection team.
Gregory Cutler
LinkedInExperience: Director (Head of DEA Compliance & Corporate Security) · Exela Pharma Sciences LLC
Former Director and Head of DEA Compliance & Corporate Security at Exela Pharma Sciences LLC (2017–2025), and Manager, DEA Compliance at Quva since 2025. Earlier he was a Diversion Investigator at the Drug Enforcement Administration (2013–2017). His headline names DEA compliance, corporate security and sourcing as his areas.
Jason Gardner
LinkedInExperience: Associate Director of DEA Compliance · Teva Pharmaceuticals
Associate Director of DEA Compliance at Teva Pharmaceuticals since 2017, after serving there as Sr. Manager, Quota and DEA Relationship Management (2013–2017) and Manager, DEA Compliance (2007–2013). The profile lists expertise in quota management, auditing and site DEA compliance management.
Larry Houck
LinkedInExperience: Attorney · Hyman, Phelps & McNamara, P.C.
Attorney at Hyman, Phelps & McNamara, P.C. since 2001, after serving as a Diversion Investigator and Staff Coordinator at the Drug Enforcement Administration (1986–2001). The profile names DEA regulatory compliance, inspections and investigations as his areas, drawing on hands-on work with controlled substance and regulated chemical issues for pharmaceutical and chemical manufacturers.
Matthew Strait
LinkedInExperience: Deputy Assistant Administrator, Offices of Diversion Control Policy & Regulatory · Drug Enforcement Administration
Former Deputy Assistant Administrator, Offices of Diversion Control Policy & Regulatory at the Drug Enforcement Administration (2020–2025), after serving as Senior Policy Advisor in the Diversion Control Division (2017–2020) and in DEA congressional affairs roles. The profile says he started as a program analyst and drug scientist in the Diversion Control Program. He has been an Advisor at Controlled Substance Strategies LLC since 2025.
Robert Symbouras
LinkedInExperience: Associate Director, DEA Compliance · Amneal Pharmaceuticals
Former Associate Director, DEA Compliance at Amneal Pharmaceuticals (2007–2015). The profile describes work across DEA compliance, including ARCOS and CSOS, quota submissions, import and export, procurement of controlled substances, suspicious order monitoring, year-end reporting, registration, and preparing for and handling DEA inspections.
Tim Lenzi
LinkedInExperience: Senior Manager, DEA Compliance · Fresenius Kabi
Senior Manager, DEA Compliance at Fresenius Kabi since 2021; the profile says he ensures controlled substance compliance for manufacturing sites and distribution centers. Earlier he was Director of Regulatory Affairs at McKesson (2020–2021) and DEA Coordinator at Wockhardt USA (2019–2020), after working at the Drug Enforcement Administration as a Diversion Investigator (1989–2015) and Supervisory Diversion Investigator (2015–2019).
Wes Graham
LinkedInExperience: Director of Controlled Substance Compliance · Patterson Companies, Inc.
Former Director of Controlled Substance Compliance at Patterson Companies (2024–2025) and at Civica Rx (2022–2023). Before that he was Associate Director, Global Controlled Substances Management & U.S. Operations at Takeda (2019–2022) and Associate Director, Controlled Substances Management at Shire (2013–2019). The profile describes overseeing programs and policies for compliance with federal, state and local controlled substance regulations.
Choose the right perspective
Match the person's seat to your question: manufacturer compliance leads for quotas, ARCOS reporting and site inspections, distributor leads for suspicious order monitoring and customer due diligence, and former DEA staff or counsel for how the agency reviews registrants and enforces the rules. Also consider your registration type, since manufacturers, distributors, researchers and pharmacies carry different obligations.
Questions to take into the conversation
- 01What should a suspicious order monitoring program include for a controlled substances distributor?
- 02How do you prepare a manufacturing site for a DEA inspection?
- 03How should a company plan quota requests and ARCOS reporting for a new controlled substance product?
Reaching DEA controlled substances compliance experts
How can I contact one of these DEA controlled substances compliance experts?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 8 companies, including Amneal Pharmaceuticals, Perrigo Company plc and Exela Pharma Sciences LLC, based on profile data retrieved on October 9, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach DEA controlled substances compliance experts?
You choose the offer, starting at $5 per person. It includes Instant Expert's 20% fee, so an offer that pays the person $100 costs you $125. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
Can an AI agent ask one of these DEA controlled substances compliance experts a question?
Yes. An agent with a USDC wallet on Base can ask one question without an Instant Expert account. It names the person, for example by the LinkedIn URL on this page, and pays per ask over x402 (HTTP 402). The person answers in writing or by voice note, and if nobody answers within 7 days, the payment goes back to the wallet automatically. x402 docs
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot and may describe past or present roles. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal